Product NDC: | 24477-030 |
Proprietary Name: | Cardene I.V. |
Non Proprietary Name: | nicardipine hydrochloride |
Active Ingredient(s): | 2.5 mg/mL & nbsp; nicardipine hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24477-030 |
Labeler Name: | EKR Therapeutics |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019734 |
Marketing Category: | NDA |
Start Marketing Date: | 19920130 |
Package NDC: | 24477-030-25 |
Package Description: | 20 BOX in 1 CASE (24477-030-25) > 10 AMPULE in 1 BOX > 10 mL in 1 AMPULE |
NDC Code | 24477-030-25 |
Proprietary Name | Cardene I.V. |
Package Description | 20 BOX in 1 CASE (24477-030-25) > 10 AMPULE in 1 BOX > 10 mL in 1 AMPULE |
Product NDC | 24477-030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | nicardipine hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19920130 |
Marketing Category Name | NDA |
Labeler Name | EKR Therapeutics |
Substance Name | NICARDIPINE HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |